An anti-frailty pill for seniors?

Nov 04, 2008

Researchers at the University of Virginia Health System report that a daily single oral dose of an investigational drug, MK-677, increased muscle mass in the arms and legs of healthy older adults without serious side effects, suggesting that it may prove safe and effective in reducing age-related frailty.

Published in the November 4, 2008 issue of Annals of Internal Medicine, the study showed that levels of growth hormone (GH) and of insulin-like growth factor I (IGF- I) in seniors who took MK-677 increased to those found in healthy young adults. The drug restored 20 percent of muscle mass loss associated with normal aging.

"Our study opens the door to the possibility of developing treatments that avert the frailty of aging," explains Dr. Michael O. Thorner, a nationally recognized researcher of growth hormone regulation and a professor of internal medicine and neurosurgery at UVA. "The search for anti-frailty medications has become increasingly important because the average American is expected to live into his or her 80s, and most seniors want to stay strong enough to remain independent as they age."

Funded by the National Institutes of Health, the two-year, double-blind, placebo-controlled, modified-crossover study involved 65 men and women ranging in age from 60 to 81.

The study drug, MK-677, mimics the action of ghrelin, a peptide that stimulates the growth hormone secretagogue receptor (GHSR). Drug developers are focusing on GHSR because it plays an important role in the regulation of growth hormone and appetite. They think it may prove to be an excellent treatment target for metabolic disorders such as those related to body weight and body composition.

According to Dr. Thorner, the UVA research was a "proof-of-concept" study that sets the stage for a larger and longer clinical trial to determine whether MK-677 is effective in people who are frail and to assess its long term safety

Source: University of Virginia Health System

Explore further: Studies yield mixed findings on high-dose flu vaccine for elders

Related Stories

Claims about the decline of the West are 'exaggerated'

7 hours ago

A new paper by Oxford researchers argues that some countries in Western Europe, and the USA, Canada, Australia and New Zealand now have birth rates that are now relatively close to replacement, that the underlying trend in ...

Norway tests out 'animal rights cops'

8 hours ago

Norwegian police is creating a unit to investigate cruelty to animals, the government said Monday, arguing that those who hurt animals often harm people too.

Recommended for you

The struggle between humans and parasites

1 hour ago

The battle between humanity and parasites is a constant struggle. As parasites grow stronger by developing immunities, new treatments must be created in response. On the frontlines of this struggle are parasitologists, scientists ...

Chikungunya kills 25 in Colombia

4 hours ago

The virus chikungunya has killed 25 people in Colombia in less than a year, the National Health Institute said Monday.

Time to move Lyme Disease Awareness Month to April?

15 hours ago

The month of May brings many things, among them Mother's Day, tulips, and Lyme Disease Awareness campaigns. But according to Dr. Richard S. Ostfeld, a disease ecologist at the Cary Institute of Ecosystem ...

An explanation of wild birds' role in avian flu outbreak

17 hours ago

Wild birds are believed to be behind the first major widespread outbreak of bird flu in the United States. The H5N2 virus has cost Midwestern turkey and chicken producers almost 13 million birds since early March, including ...

User comments : 0

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.